Development of a next-generation chikungunya virus vaccine based on the HydroVax platform.
Chikungunya virus (CHIKV) is an emerging/re-emerging mosquito-borne pathogen responsible for explosive epidemics of febrile illness characterized by debilitating polyarthralgia and the risk of lethal infection among the most severe cases. Despite the public health risk posed by CHIKV, no vaccine is...
Saved in:
| Main Authors: | Dawn K Slifka, Hans-Peter Raué, Whitney C Weber, Takeshi F Andoh, Craig N Kreklywich, Victor R DeFilippis, Daniel N Streblow, Mark K Slifka, Ian J Amanna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-07-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010695&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
by: Whitney C Weber, et al.
Published: (2025-03-01) -
Survivin Interference and SurVaxM as an Adjunct Therapy for Glioblastoma Multiforme
by: Willie James Elliott, et al.
Published: (2025-05-01) -
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.
by: John M Powers, et al.
Published: (2023-03-01) -
Chikungunya
by: C. Roxanne Rutledge-Connelly, et al.
Published: (2007-04-01) -
Chikungunya
by: C. Roxanne Rutledge-Connelly, et al.
Published: (2007-04-01)